Ramiro Sanchez serves as Executive at Cerevel Therapeutics Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Ramiro Sanchez has executed 10 insider transactions totaling $1.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 2, 2026 involved receiving (via award) 3,806 shares valued at $45.0K.
Ramiro Sanchez currently holds 3,806 shares of Cerevel Therapeutics Holdings, Inc. (CERE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ramiro Sanchez has been a net seller of CERE stock. They have purchased $0 and sold $1.6M worth of shares.
Ramiro Sanchez's most recent insider trade was on Jan 2, 2026, when they sold 3,806 shares at $11.82 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 26, 2023 | CERE | $424.7K | Sale | 10,000 | $42.47 | Planned |
| Dec 26, 2023 | CERE | $35.0K | Option Exercise | 10,000 | $3.50 | Planned |
| Dec 20, 2023 | CERE | $420.5K | Sale | 10,152 | $41.42 | Discretionary |
| Dec 19, 2023 | CERE | $0 | Option Exercise | 24,825 | $N/A | Discretionary |
| Dec 15, 2023 | CERE | $310.4K | Sale | 7,500 | $41.39 | Discretionary |
| Dec 15, 2023 | CERE | $74.1K | Option Exercise | 7,500 | $9.88 | Discretionary |
| Dec 7, 2023 | CERE | $35.0K | Option Exercise | 10,000 | $3.50 | Planned |
| Dec 7, 2023 | CERE | $413.7K | Sale | 10,000 | $41.37 | Planned |